Combination therapy for chronic hepatitis B.
Schalm
Solko W
SW
Department of Gastroenterology and Hepatology, Erasmus MC University Medical Center, Room Ca 326, Dr. Molewaterplein 40, 3015 GD Rotterdam, The Netherlands. s.schalm@erasmusmc.nl
D000225:Adenine / Q000031:analogs & derivatives* / Q000627:therapeutic use; D000998:Antiviral Agents / Q000627:therapeutic use*; D004359:Drug Therapy, Combination; D006510:Hepatitis B Antibodies / Q000032:analysis; D006513:Hepatitis B e Antigens / Q000032:analysis / Q000276:immunology; D006515:Hepatitis B virus / Q000276:immunology; D019694:Hepatitis B, Chronic / Q000188:drug therapy*; D006801:Humans; D007372:Interferons / Q000627:therapeutic use*; D019259:Lamivudine / Q000627:therapeutic use*; D009705:Nucleosides / Q000627:therapeutic use*; D063065:Organophosphonates; D018894:Reverse Transcriptase Inhibitors / Q000627:therapeutic use*; D014765:Viral Vaccines / Q000627:therapeutic use*
D000998:Antiviral Agents; D006510:Hepatitis B Antibodies; D006513:Hepatitis B e Antigens; D009705:Nucleosides; D063065:Organophosphonates; D018894:Reverse Transcriptase Inhibitors; D014765:Viral Vaccines; D019259:Lamivudine; C053001:adefovir; D007372:Interferons; D000225:Adenine